查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1844182

血管閉合裝置市場按產品類型、手術類型、接入點、最終用戶和分銷管道分類 - 全球預測 2025-2032

Vascular Closure Device Market by Product Type, Procedure Type, Access Site, End User, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年血管閉合裝置市場將成長至 31.1 億美元，複合年成長率為 7.73%。

主要市場統計數據
基準年2024年 17.1億美元
預計2025年 18.5億美元
預測年份：2032年 31.1億美元
複合年成長率（%） 7.73%

權威介紹，闡述重塑血管閉合裝置選擇的臨床重點、監管壓力和程序趨勢

血管閉合裝置處於臨床需求、手術效率和器械創新的交會點。過去十年，臨床醫生和醫院管理人員優先考慮能夠縮短止血時間、降低併發症發生率、提高患者周轉率且不影響手術安全的解決方案。為此，技術開發人員推出了各種機械和生物學方法，旨在解決穿刺部位的挑戰，並與各種手術流程整合。

監管途徑、報銷壓力以及日益以結果主導的採購環境持續影響著設備的開發和應用。隨著醫療機構尋求顯著縮短住院時間和減少術後併發症，臨床證據和實際表現數據正成為採購決策的關鍵因素。同時，諸如橈動脈入路的擴展以及低風險干預措施向門診轉移等手術趨勢正在重新定義臨床需求和用例。

綜上所述，這些因素共同創造了一個動態的環境，在易用性、安全性以及與微創方法相容性方面的逐步改進，有可能帶來顯著的臨床和操作效益。本引言確立了本摘要其餘部分探討的核心主題：技術差異化、程序一致性、監管考慮因素以及醫療服務提供者和付款人不斷變化的需求。

臨床、設備創新和採購動態的重大轉型正在重新定義血管閉合設備格局

在臨床發展、技術進步和醫療服務模式調整的推動下，血管閉合器材的市場格局正經歷數次變革。首先，臨床上明顯傾向於使用能夠促進早期活動和減少穿刺部位併發症的器械，從而提高了安全性和易用性的標準。臨床醫生越來越青睞那些能夠最大程度縮短手動按壓時間並適應當日出院流程的解決方案，尤其是在門診病人和門診環境中。

其次，器械創新正從單純的機械解決方案轉向混合生物活性方法，旨在促進止血並限制異物反應。這一趨勢包括改進縫合閉合技術、開發具有最佳化生物整合的可吸收栓塞，以及即使在具有挑戰性的血流動力學條件下也能有效黏附的密封劑。同時，製造商正致力於提高可用性，包括符合人體工學的輸送系統、簡化的培訓工作流程和清晰的操作指南，以減少臨床結果的差異性。

第三，醫療保健採購的結構性動態正在改變打入市場策略。醫院系統和門診手術中心正在整合其採購框架，並要求提供可靠的真實世界證據和上市後監測數據。這些變化要求製造商制定全面的價值主張，將臨床結果與營運效益和資源利用率連結起來。因此，設備製造商、臨床領導者和醫療系統之間的策略合作正成為實現應用的關鍵途徑。

2025 年美國關稅如何改變整個醫療設備價值鏈的供應鏈策略、產品優先順序和定價動態

2025年美國關稅的實施對整個供應鏈產生了顯著影響，影響了設備製造商的零件採購、製造策略和定價動態。對某些進口材料和次組件的關稅促使企業重新評估其供應商佈局，加速關鍵零件的近岸外包，在某些情況下，甚至重新設計其供應鏈，以降低關稅上調帶來的風險。這些商業反應對於先前依賴單一來源進口精密聚合物、生物製藥原料和特殊供應零件的企業尤其明顯。

同時，關稅帶來的成本壓力促使一些製造商重新評估產品系列，優先投資利潤率更高的差異化技術，而非商品化產品。這種轉變也影響了競爭定位，供應鏈彈性較低的小型企業面臨利潤率壓縮，而大型企業則利用其規模來吸收或抵消不斷上漲的關稅。此外，醫療系統採購團隊正在透過更嚴格的成本效益分析來應對下游價格調整，不僅關注單位成本，還關注醫療總成本和供應商可靠性。

最後，監管和貿易的不確定性再次引發了對庫存韌性和合約保障的關注。企業擴大與供應商協商長期契約，實現供應商多元化，並投資於供應鏈視覺化工具，以預測和應對與關稅相關的中斷。因此，2025年的關稅環境引發了製造、採購和商業營運領域的策略調整。

細分主導的洞察揭示了產品設計、程序環境、訪問站點動態、最終用戶需求和通路如何影響採用模式

對細分市場的細緻考察揭示了臨床需求與產品功能和商業管道的交匯點。對於膠原蛋白塞，牛蛋白塞和合成膠原蛋白蛋白塞之間的區別會影響臨床醫生基於生物相容性和吸收特性的偏好，而封閉劑的選擇（例如幾丁聚醣封閉劑與聚乙二醇封閉劑）則反映了粘合強度和炎症潛能之間的權衡。這些產品層面的差異不僅影響臨床選擇，還會影響培訓需求和庫存規劃。

從手術類型來看，診斷性手術包括血管造影術手術和血流動力學監測，其中快速止血和盡量減少對血管造影的干擾至關重要；而介入性手術包括介入心臟病學和外周介入，這些手術需要在使用大口徑鞘套的情況下進行高抗凝血和可靠的閉合。入路部位——股動脈還是橈動脈——仍然是決定設備相關性的關鍵因素，其中橈動脈入路推動了對低調、易於使用的系統的需求，而股動脈入路則維持了對堅固的機械閉合方案的需求。

終端使用場景（門診手術中心、診所和醫院）的差異決定了購買行為和設備採用時間表。門診手術中心優先考慮吞吐量和易用性，而醫院則強調全面的臨床證據和多操作員適用性。銷售管道動態直接分銷商和第三方經銷商，直接分銷商提供更緊密的臨床培訓和價值主張一致性，而第三方經銷商提供廣泛且覆蓋異質基本客群的服務。這些細分層次共同促成了有針對性的產品開發和差異化的市場策略。

美洲、歐洲、中東和非洲以及亞太地區的區域動態和戰略影響將影響每種市場方法

區域動態對臨床偏好、監管方法和商業策略有重大影響。美洲的臨床實務模式具有以下特點：廣泛採用橈動脈和股動脈入路技術，先進的報銷模式日益重視效率，以及大型綜合醫療體系的集中，這些體系在獲得確鑿證據支持的情況下可以加速創新的採用。供應鏈的接近性和國內製造能力也在採購決策中發揮作用，影響企業在該地區建立分銷和服務模式的方式。

在歐洲、中東和非洲，法規環境差異化和醫療服務提供環境多樣化，為市場參與企業帶來了挑戰和機會。各國的保險報銷結構差異龐大，國家臨床指引也往往會影響設備的選擇。同時，歐洲、中東和非洲地區的多個市場對微創治療和門診干預的需求日益成長，這導致對注重易用性和可預測結果的設備的需求增加。

亞太地區手術量快速成長、介入治療能力不斷提升以及支付方格局多元化，共同構成了一個複雜卻極具發展潛力的環境。該地區各國的監管時間表和區域製造生態系統各不相同，這迫使製造商尋求靈活的商業模式，以兼顧集中式醫院網路和快速擴張的門診醫療機構的需求。總體而言，區域策略必須量身定做，使臨床應用促進因素與監管現實和供應鏈考量相一致。

競爭格局分析和公司策略凸顯了現有企業、挑戰者和合作者如何塑造設備組合和夥伴關係關係的未來

血管閉合裝置領域的競爭格局呈現一種平衡：現有企業憑藉其臨床經驗，與新參與企業在技術創新和成本效率方面競爭。現有企業通常受益於與大型醫院系統的深厚關係、全面的培訓計劃以及豐富的上市後監測數據，這些數據為產品的迭代改進提供了資訊。相反，挑戰者則經常利用利基市場機會，推出差異化材料、簡化的部署機制以及能夠證明特定手術方案優越性的有針對性的臨床證據。

夥伴關係和策略聯盟正變得越來越普遍，器材製造商與契約製造製造商、學術中心和醫療系統合作，以加速臨床檢驗和生產規模擴大。資本配置模式表明，企業更傾向於投資那些能夠縮短手術時間或顯著降低併發症風險的技術，因為這些成果與醫療系統的品質指標和報銷優先事項密切相關。此外，我們持續看到整合和選擇性收購的趨勢，因為大型公司正在尋求擴大產品系列，並確保在不影響內部開發的情況下獲得創新技術。

對製造商而言，在法規合規性、供應鏈韌性和持續臨床參與之間保持平衡至關重要。投資強大的臨床醫生教育、透明的績效評估和自適應供應鏈的公司將能夠應對不斷變化的採購標準，並抓住流程和醫療服務模式轉變帶來的機會。

為製造商和相關人員提供實用的優先建議，以加速採用、加強供應鏈並使證據與醫療保健提供者的優先事項保持一致

為了抓住程序性護理領域的新機遇，產業領導者應採取一種將產品創新、臨床證據產生和供應鏈韌性相結合的協作方式。首先，優先考慮設計改進，以降低程序複雜性並提高部署一致性，無論操作員的技能水平如何。改進的可用性和直覺的交付系統降低了培訓門檻，並加速了其在門診和醫院環境中的採用。其次，投資於臨床證據項目，將設備性能與醫療保健提供者衡量的運作結果（例如止血時間、恢復活動的時間以及術後併發症的減少）明確地結合起來。

同時，我們透過多元化供應商、評估關鍵零件的近岸外包選項以及協商在關稅和貿易不確定性下提供靈活性的合約條款來加強我們的供應鏈策略。在商業性，我們透過提供差異化的價值提案來客製化我們的上市模式，以滿足最終用戶的需求。我們強調為醫院系統提供培訓和服務包，為門診手術中心提供吞吐量和易用性優勢，並在直銷不切實際的情況下利用我們的分銷商網路覆蓋廣泛的地區。最後，我們與臨床領導者和醫療系統買家建立合作夥伴關係，共同開發證據，部署試驗計畫，並確保長期採用夥伴關係，以表明對結果的共用課責。

這些措施結合起來可以提高競爭力，減少營運衝擊，並增加設備創新產生持久臨床和商業性影響的可能性。

結合臨床醫生訪談、證據綜合和數據三角測量的透明調查方法可確保獲得可靠、可操作的見解

本摘要所依據的研究結合了對臨床醫生、採購主管和行業高管的初步研究，以及對監管文件、同行評審臨床文獻和真實世界資訊來源的嚴格二次研究。初步研究包括結構化訪談和定性深入對話，旨在揭示臨床醫生的工作流程限制、培訓需求和採購決策促進因素。這些調查也輔以與衛生系統管理人員的諮詢，以明確營運重點和資源分配考量。

二次研究包括對臨床研究、操作指南和監管文件的系統性回顧，以檢驗關於器械安全性和性能的聲明。我們運用資料三角測量技術，將訪談所得見解與已發表的結果和器械標籤資訊進行比對，以確保建議反映的是綜合證據，而非孤立的軼事。我們謹慎地將獨特資訊匿名化，並將經驗總結成適用於不同組織情境的通用主題。

品質保證流程包括臨床專家的最後覆核、引用的監管文獻的檢驗以及反覆的審查週期，以完善結論。本調查方法強調透明度、可重複性以及與行業最佳實踐的一致性，為相關人員提供可靠的策略和營運決策基礎。

將臨床需求、技術創新和策略行動連結起來的簡明綜合結論，以實現持續採用和改善結果

總而言之，血管閉合器材領域正面臨雙重壓力：臨床對更安全、更快速止血的需求，以及商業性需求對可證明價值的獎勵。技術創新正在釋放機遇，以滿足先前未被滿足的需求，而醫療服務流程的趨勢和變革正在重新定義這些器材的使用方式和場所。能夠成功將產品設計與臨床醫生工作流程、監管要求和彈性供應鏈相結合的組織，將最有可能將其創新轉化為持久的應用。

此外，不斷變化的商業環境（包括貿易政策變化、採購整合和區域差異）需要靈活的策略，將可靠的臨床證據與靈活的分銷和生產方法相結合。透過專注於有針對性的細分市場、嚴格的結果衡量以及與醫療系統的合作試驗，相關人員可以在管理營運風險的同時加速有意義的應用。最終，嚴謹的、以證據主導的方法對於將技術潛力轉化為更好的患者治療效果和永續的商業性績效至關重要。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 擴大採用生物可吸收血管閉合系統來促進患者康復並減少併發症
  • 將即時超音波引導整合到閉合手術中可提高手術的準確性和結果。
  • 對微創和快速止血解決方案的需求正在推動向基於聚合物的封閉裝置的轉變。
  • 人們對抗菌塗層封閉裝置的興趣日益濃厚，以降低大容量導管插入實驗室的感染風險。
  • 不斷演變的報銷政策和簡化的監管途徑將如何影響創新 VCD 的市場准入
  • 縫合線和夾子閉合技術之間的競爭日益激烈，影響定價和發展策略

第6章：2025年美國關稅的累積影響

第7章：人工智慧的累積影響，2025年

8. 血管閉合裝置市場（依產品類型）

  • 基於夾子的設備
  • 膠原蛋白塞裝置
    • 牛膠原蛋白塞
    • 合成膠原蛋白塞
  • 外部壓縮裝置
  • 基於密封劑的設備
    • 幾丁聚醣密封膠
    • 聚乙二醇密封膠
  • 基於縫合的設備

9. 血管閉合裝置市場（依手術類型）

  • 診斷程序
    • 血管造影術
    • 血流動力學監測
  • 干預程序
    • 心血管介入
    • 周邊血管介入治療

第 10 章血管閉合裝置市場進入網站

  • 股動脈通路
  • 橈動脈入路

第 11 章血管閉合裝置市場（依最終用戶）

  • 門診手術中心
  • 診所
  • 醫院

第 12 章血管閉合裝置市場（依通路）

  • 直銷
  • 第三方經銷商

第13章血管閉合裝置市場（按地區）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章血管閉合裝置市場（依類別）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章血管閉合裝置市場（依國家）

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章競爭格局

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Abbott Laboratories
    • Terumo Corporation
    • Teleflex Incorporated
    • Cardinal Health, Inc.
    • Boston Scientific Corporation
    • Becton, Dickinson and Company
    • Merit Medical Systems, Inc.
    • B. Braun Melsungen AG
    • Cook Medical LLC
    • Lake Region Medical, Inc.
Product Code: MRR-ED54C46E8A80

The Vascular Closure Device Market is projected to grow by USD 3.11 billion at a CAGR of 7.73% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 1.71 billion
Estimated Year [2025] USD 1.85 billion
Forecast Year [2032] USD 3.11 billion
CAGR (%) 7.73%

An authoritative introduction framing clinical priorities, regulatory pressures, and procedural trends that are reshaping vascular closure device choices

The vascular closure device landscape sits at the intersection of clinical need, procedural efficiency, and device innovation. Over the past decade, clinicians and hospital administrators have prioritized solutions that reduce time to hemostasis, lower complication rates, and enable faster patient throughput without compromising procedural safety. Consequently, technology developers have responded with a range of mechanical and biological approaches designed to address distinct access-site challenges while integrating with diverse procedural workflows.

Regulatory pathways, reimbursement pressures, and an increasingly outcomes-driven purchasing environment continue to shape device development and adoption. As institutions seek demonstrable reductions in length of stay and post-procedural complications, clinical evidence and real-world performance data have become decisive factors in procurement decisions. At the same time, procedural trends such as the expansion of radial access and the shift of lower-risk interventions to ambulatory settings are redefining clinical requirements and use cases.

Taken together, these forces create a dynamic environment where incremental improvements in ease of use, safety profile, and compatibility with minimally invasive approaches can yield significant clinical and operational advantages. This introduction establishes the core themes explored throughout the rest of this summary: technological differentiation, procedural alignment, regulatory considerations, and the changing needs of providers and payers.

Key transformative shifts in clinical practice, device innovation, and procurement dynamics that are redefining the vascular closure device landscape

The landscape for vascular closure devices is undergoing several transformative shifts driven by clinical practice evolution, technological refinement, and care-delivery reorganization. First, there is a clear clinical push toward devices that facilitate earlier ambulation and reduce access-site complications, which in turn raises the bar for demonstrable safety and ease of deployment. Clinicians increasingly favor solutions that minimize manual compression time and are compatible with same-day discharge pathways, especially in outpatient or ambulatory settings.

Second, device innovation is migrating from purely mechanical solutions to hybrid and biologically active approaches that aim to accelerate hemostasis while reducing foreign-body reactions. This trend includes refinement of suture-based closure techniques, development of resorbable plugs with optimized biointegration, and sealants formulated to adhere effectively under challenging hemodynamic conditions. Meanwhile, manufacturers are focusing on usability enhancements-ergonomic delivery systems, simplified training workflows, and clear procedural guidance-to reduce variability in clinical outcomes.

Third, the structural dynamics of healthcare procurement are altering market access strategies. Hospital systems and ambulatory surgical centers are consolidating purchasing frameworks and demanding robust real-world evidence and post-market surveillance data. These shifts require manufacturers to develop comprehensive value dossiers that link clinical performance to operational benefits and resource utilization. As a result, strategic collaborations between device companies, clinical leaders, and health systems are becoming an essential pathway to adoption.

How the 2025 United States tariff measures reshaped supply chain strategies, product prioritization, and pricing dynamics across the device value chain

The introduction of United States tariff measures in 2025 has exerted a notable influence across the supply chain, affecting component sourcing, manufacturing strategies, and pricing dynamics for device manufacturers. Tariffs on certain imported materials and subassemblies have prompted companies to reassess supplier footprints, accelerate nearshoring of critical components, and in some cases, redesign supply chains to mitigate exposure to incremental duties. These operational responses have been particularly pronounced for firms that previously relied on single-source imports for precision polymers, biologic feedstocks, or proprietary delivery components.

In parallel, tariff-driven cost pressures have led several manufacturers to re-evaluate product portfolios and prioritize investments in higher-margin, differentiated technologies over commoditized offerings. This shift has implications for competitive positioning, as smaller players with less flexible supply chains face heightened margin compression while larger organizations leverage scale to absorb or offset duty increases. Additionally, procurement teams at health systems are responding to downstream pricing adjustments by conducting more rigorous cost-benefit analyses, emphasizing total cost of care and supplier reliability over unit price alone.

Finally, regulatory and trade uncertainty has prompted a renewed focus on inventory resilience and contractual safeguards. Companies are increasingly negotiating longer-term agreements with suppliers, diversifying vendor bases, and investing in supply chain visibility tools to anticipate and respond to tariff-related disruptions. As a result, the 2025 tariff environment has catalyzed strategic realignment across manufacturing, procurement, and commercial operations.

Segment-driven insights revealing how product design, procedural context, access site dynamics, end-user requirements, and distribution paths shape adoption patterns

A nuanced examination of segmentation reveals where clinical needs intersect with product capabilities and commercial channels. Based on product type, the field includes Clip Based Devices, Collagen Plug Devices, External Compression Devices, Sealant Based Devices, and Suture Based Devices; within collagen plugs, distinctions between Bovine Collagen Plugs and Synthetic Collagen Plugs influence clinician preference based on biocompatibility concerns and resorption profiles, while sealant choices such as Chitosan Sealants and Polyethylene Glycol Sealants reflect trade-offs between adhesive strength and inflammatory potential. These product-level differences affect not only clinical selection but also training requirements and inventory planning.

Turning to procedure type, diagnostic procedures encompass Angiographic Procedures and Hemodynamic Monitoring where rapid hemostasis and minimal interference with vascular imaging are paramount, whereas interventional procedures include Cardiovascular Interventions and Peripheral Vascular Interventions that demand closure reliability under higher anticoagulation or larger-bore sheath scenarios. Access site segmentation-Femoral Access versus Radial Access-continues to be a critical determinant of device relevance, with radial access driving demand for lower-profile, user-friendly systems and femoral access sustaining the need for robust mechanical closure options.

End user distinctions among Ambulatory Surgical Centers, Clinics, and Hospitals shape purchasing behavior and device adoption timelines, as ambulatory settings prioritize throughput and ease of use while hospitals emphasize comprehensive clinical evidence and multi-operator applicability. Distribution channel dynamics split between Direct Sales and Third Party Distributors, with direct sales enabling closer clinical training and value proposition alignment and third party distributors offering breadth and reach across heterogeneous customer bases. Together, these segmentation layers create multiple pathways for targeted product development and differentiated go-to-market strategies.

Regional dynamics and strategic implications across the Americas, Europe, Middle East & Africa, and Asia-Pacific that inform tailored market approaches

Regional dynamics exert a strong influence on clinical preferences, regulatory approaches, and commercial strategies. In the Americas, clinical practice patterns are characterized by broad adoption of both radial and femoral access techniques, progressive reimbursement models that increasingly reward efficiency, and a concentrated group of large integrated health systems that can accelerate adoption of innovations when supported by robust evidence. Supply chain proximity and domestic manufacturing capabilities also play a role in procurement decisions, influencing how companies structure distribution and service models within the region.

In Europe, Middle East & Africa, heterogeneous regulatory environments and a diversity of healthcare delivery settings create both challenges and opportunities for market entrants. Reimbursement mechanisms vary widely across countries, and local clinical guidelines often influence device selection more than multinational promotional efforts. Meanwhile, several EMEA markets show a growing appetite for minimally invasive approaches and outpatient interventions, which in turn drives demand for devices that prioritize ease of use and predictable outcomes.

Across Asia-Pacific, the combination of rapid procedural growth, expanding interventional capabilities, and varied payer landscapes creates a complex but high-potential environment. Countries within the region differ in their regulatory timelines and local manufacturing ecosystems, prompting manufacturers to pursue flexible commercial models that accommodate both centralized hospital networks and rapidly expanding ambulatory providers. Overall, regional strategies must be tailored to align clinical adoption drivers with regulatory realities and supply chain considerations.

Competitive landscape analysis and corporate strategies highlighting how incumbents, challengers, and collaborators are shaping the future of device portfolios and partnerships

Competitive dynamics in the vascular closure device arena are characterized by a balance between established players that leverage clinical legacy and newer entrants that compete on innovation and cost-efficiency. Incumbent firms often benefit from deep relationships with large hospital systems, comprehensive training programs, and extensive post-market surveillance data that inform iterative product improvements. Conversely, challenger companies frequently exploit niche opportunities by introducing differentiated materials, simplified deployment mechanisms, or focused clinical evidence demonstrating specific procedural advantages.

Partnerships and strategic alliances are increasingly common, as device makers collaborate with contract manufacturers, academic centers, and health systems to accelerate clinical validation and scale manufacturing. Capital allocation patterns reveal a preference for funding technologies that reduce procedural time or demonstrably lower complication risks, because these outcomes align closely with health system quality metrics and reimbursement priorities. Additionally, a trend toward consolidation and selective acquisition remains visible, as larger organizations seek to broaden product portfolios and secure access to innovative technologies without internal development lag.

For manufacturers, maintaining a balance between regulatory compliance, supply chain resilience, and continuous clinical engagement is essential. Companies that invest in robust clinician education, transparent performance measurement, and adaptable supply arrangements are better positioned to navigate shifting procurement criteria and to capture opportunities presented by changes in procedural practice and care delivery models.

Practical, prioritized recommendations for manufacturers and stakeholders to accelerate adoption, strengthen supply chains, and align evidence with provider priorities

Industry leaders should pursue a coordinated approach that combines product innovation, clinical evidence generation, and supply chain resilience to capture emerging opportunities in procedural care. First, prioritize design enhancements that reduce procedural complexity and improve deployment consistency across operator skill levels; usability improvements and intuitive delivery systems lower training barriers and accelerate uptake in ambulatory and hospital settings. Second, invest in clinical evidence programs that clearly align device performance with operational outcomes valued by providers, such as time to hemostasis, return-to-activity timelines, and reduced post-procedural complications.

Simultaneously, strengthen supply chain strategies by diversifying supplier bases, assessing nearshoring options for critical components, and negotiating contractual terms that provide flexibility under tariff and trade uncertainties. Commercially, tailor go-to-market models to end-user needs by offering differentiated value propositions: provide training and service bundles for hospital systems, emphasize throughput and ease-of-use benefits for ambulatory surgical centers, and leverage distributor networks for broad geographic reach where direct sales are impractical. Finally, cultivate partnerships with clinical leaders and health system purchasers to co-develop evidence, deploy pilot programs, and secure long-term adoption commitments that demonstrate shared accountability for outcomes.

Taken together, these actions will improve competitiveness, reduce exposure to operational shocks, and increase the likelihood that device innovations translate into sustained clinical and commercial impact.

Transparent research methodology combining clinician interviews, evidence synthesis, and data triangulation to ensure credible, actionable insights

The research underpinning this summary combined primary interviews with clinicians, procurement leaders, and industry executives alongside rigorous secondary review of regulatory filings, peer-reviewed clinical literature, and real-world evidence sources. Primary research consisted of structured interviews and qualitative depth conversations designed to surface clinician workflow constraints, training needs, and procurement decision drivers. These engagements were complemented by advisory consultations with health system administrators to contextualize operational priorities and resource allocation considerations.

Secondary research included systematic review of clinical studies, procedure guidelines, and regulatory documentation to validate claims of device safety and performance. Data triangulation techniques were applied to reconcile insights from interviews with published outcomes and device labeling information, ensuring that recommendations reflect convergent evidence rather than isolated anecdotes. Care was taken to anonymize proprietary information and to synthesize learnings into generalized themes applicable across different organizational contexts.

Quality assurance processes included cross-checks by clinical subject-matter experts, verification of cited regulatory references, and iterative review cycles to refine conclusions. The methodology emphasizes transparency, repeatability, and alignment with industry best practices to provide stakeholders with a credible basis for strategic planning and operational decision-making.

Concise concluding synthesis connecting clinical needs, technological innovation, and strategic actions to achieve durable adoption and improved outcomes

In conclusion, the vascular closure device domain is evolving under the twin pressures of clinical demand for safer, faster hemostasis and commercial imperatives that reward demonstrable value. Technological innovation is unlocking opportunities to address previously unmet needs, while procedural trends and care-delivery shifts are redefining where and how these devices are used. Organizations that successfully align product design with clinician workflows, regulatory expectations, and resilient supply chains will be best positioned to translate innovation into durable adoption.

Moreover, the shifting commercial environment-accentuated by trade policy changes, procurement consolidation, and regional variability-requires flexible strategies that combine robust clinical evidence with adaptive distribution and manufacturing approaches. By focusing on targeted segmentation, rigorous outcome measurement, and collaborative pilots with health systems, stakeholders can accelerate meaningful adoption while managing operational risk. Ultimately, a disciplined, evidence-led approach will be essential for converting technological potential into improved patient outcomes and sustainable commercial performance.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Increasing adoption of bioabsorbable vascular closure systems to enhance patient recovery and reduce complications
  • 5.2. Integration of real-time ultrasound guidance in closure procedures improving procedural accuracy and outcomes
  • 5.3. Shift toward polymer-based closure devices driven by demand for minimally invasive and faster hemostasis solutions
  • 5.4. Growing interest in antimicrobial-coated closure devices to mitigate infection risks in high-volume cath labs
  • 5.5. Impact of evolving reimbursement policies and streamlined regulatory pathways on market entry for innovative VCDs
  • 5.6. Rising competition from suture-mediated versus clip-based closure technologies shaping pricing and development strategies

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Vascular Closure Device Market, by Product Type

  • 8.1. Clip Based Devices
  • 8.2. Collagen Plug Devices
    • 8.2.1. Bovine Collagen Plugs
    • 8.2.2. Synthetic Collagen Plugs
  • 8.3. External Compression Devices
  • 8.4. Sealant Based Devices
    • 8.4.1. Chitosan Sealants
    • 8.4.2. Polyethylene Glycol Sealants
  • 8.5. Suture Based Devices

9. Vascular Closure Device Market, by Procedure Type

  • 9.1. Diagnostic Procedures
    • 9.1.1. Angiographic Procedures
    • 9.1.2. Hemodynamic Monitoring
  • 9.2. Interventional Procedures
    • 9.2.1. Cardiovascular Interventions
    • 9.2.2. Peripheral Vascular Interventions

10. Vascular Closure Device Market, by Access Site

  • 10.1. Femoral Access
  • 10.2. Radial Access

11. Vascular Closure Device Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Clinics
  • 11.3. Hospitals

12. Vascular Closure Device Market, by Distribution Channel

  • 12.1. Direct Sales
  • 12.2. Third Party Distributors

13. Vascular Closure Device Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Vascular Closure Device Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Vascular Closure Device Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Abbott Laboratories
    • 16.3.2. Terumo Corporation
    • 16.3.3. Teleflex Incorporated
    • 16.3.4. Cardinal Health, Inc.
    • 16.3.5. Boston Scientific Corporation
    • 16.3.6. Becton, Dickinson and Company
    • 16.3.7. Merit Medical Systems, Inc.
    • 16.3.8. B. Braun Melsungen AG
    • 16.3.9. Cook Medical LLC
    • 16.3.10. Lake Region Medical, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. VASCULAR CLOSURE DEVICE MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. VASCULAR CLOSURE DEVICE MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. VASCULAR CLOSURE DEVICE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY CLIP BASED DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY CLIP BASED DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY CLIP BASED DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY CLIP BASED DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY CLIP BASED DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY CLIP BASED DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY BOVINE COLLAGEN PLUGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY BOVINE COLLAGEN PLUGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY BOVINE COLLAGEN PLUGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY BOVINE COLLAGEN PLUGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY BOVINE COLLAGEN PLUGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY BOVINE COLLAGEN PLUGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY SYNTHETIC COLLAGEN PLUGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY SYNTHETIC COLLAGEN PLUGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY SYNTHETIC COLLAGEN PLUGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY SYNTHETIC COLLAGEN PLUGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY SYNTHETIC COLLAGEN PLUGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY SYNTHETIC COLLAGEN PLUGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY EXTERNAL COMPRESSION DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY EXTERNAL COMPRESSION DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY EXTERNAL COMPRESSION DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY EXTERNAL COMPRESSION DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY EXTERNAL COMPRESSION DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY EXTERNAL COMPRESSION DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY CHITOSAN SEALANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY CHITOSAN SEALANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY CHITOSAN SEALANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY CHITOSAN SEALANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY CHITOSAN SEALANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY CHITOSAN SEALANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY POLYETHYLENE GLYCOL SEALANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY POLYETHYLENE GLYCOL SEALANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY POLYETHYLENE GLYCOL SEALANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY POLYETHYLENE GLYCOL SEALANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY POLYETHYLENE GLYCOL SEALANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY POLYETHYLENE GLYCOL SEALANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY SUTURE BASED DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY SUTURE BASED DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY SUTURE BASED DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY SUTURE BASED DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY SUTURE BASED DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY SUTURE BASED DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY ANGIOGRAPHIC PROCEDURES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY ANGIOGRAPHIC PROCEDURES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY ANGIOGRAPHIC PROCEDURES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY ANGIOGRAPHIC PROCEDURES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY ANGIOGRAPHIC PROCEDURES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY ANGIOGRAPHIC PROCEDURES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY HEMODYNAMIC MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY HEMODYNAMIC MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY HEMODYNAMIC MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY HEMODYNAMIC MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY HEMODYNAMIC MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY HEMODYNAMIC MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY CARDIOVASCULAR INTERVENTIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY CARDIOVASCULAR INTERVENTIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY CARDIOVASCULAR INTERVENTIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY CARDIOVASCULAR INTERVENTIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY CARDIOVASCULAR INTERVENTIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY CARDIOVASCULAR INTERVENTIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR INTERVENTIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR INTERVENTIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR INTERVENTIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR INTERVENTIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR INTERVENTIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR INTERVENTIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY FEMORAL ACCESS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY FEMORAL ACCESS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY FEMORAL ACCESS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY FEMORAL ACCESS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY FEMORAL ACCESS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY FEMORAL ACCESS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY RADIAL ACCESS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY RADIAL ACCESS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY RADIAL ACCESS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY RADIAL ACCESS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY RADIAL ACCESS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY RADIAL ACCESS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 158. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 159. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 160. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 161. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2024 (USD MILLION)
  • TABLE 162. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2025-2032 (USD MILLION)
  • TABLE 163. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2024 (USD MILLION)
  • TABLE 164. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2025-2032 (USD MILLION)
  • TABLE 165. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 166. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 167. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2024 (USD MILLION)
  • TABLE 168. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2025-2032 (USD MILLION)
  • TABLE 169. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2024 (USD MILLION)
  • TABLE 170. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2025-2032 (USD MILLION)
  • TABLE 171. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2024 (USD MILLION)
  • TABLE 172. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2025-2032 (USD MILLION)
  • TABLE 173. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 174. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 175. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 176. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. NORTH AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 180. NORTH AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2024 (USD MILLION)
  • TABLE 182. NORTH AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2025-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2024 (USD MILLION)
  • TABLE 184. NORTH AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2025-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 186. NORTH AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 187. NORTH AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2024 (USD MILLION)
  • TABLE 188. NORTH AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2025-2032 (USD MILLION)
  • TABLE 189. NORTH AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2024 (USD MILLION)
  • TABLE 190. NORTH AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2025-2032 (USD MILLION)
  • TABLE 191. NORTH AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2024 (USD MILLION)
  • TABLE 192. NORTH AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2025-2032 (USD MILLION)
  • TABLE 193. NORTH AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 194. NORTH AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 195. NORTH AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 196. NORTH AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. LATIN AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 200. LATIN AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 201. LATIN AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2024 (USD MILLION)
  • TABLE 202. LATIN AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2025-2032 (USD MILLION)
  • TABLE 203. LATIN AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2024 (USD MILLION)
  • TABLE 204. LATIN AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2025-2032 (USD MILLION)
  • TABLE 205. LATIN AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 206. LATIN AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 207. LATIN AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2024 (USD MILLION)
  • TABLE 208. LATIN AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2025-2032 (USD MILLION)
  • TABLE 209. LATIN AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2024 (USD MILLION)
  • TABLE 210. LATIN AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2025-2032 (USD MILLION)
  • TABLE 211. LATIN AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2024 (USD MILLION)
  • TABLE 212. LATIN AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2025-2032 (USD MILLION)
  • TABLE 213. LATIN AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 214. LATIN AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 215. LATIN AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 216. LATIN AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2025-2032 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPE VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 241. EUROPE VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPE VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPE VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPE VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPE VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPE VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPE VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPE VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2025-2032 (USD MILLION)
  • TABLE 251. EUROPE VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPE VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPE VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 257. MIDDLE EAST VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. MIDDLE EAST VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. MIDDLE EAST VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 260. MIDDLE EAST VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 261. MIDDLE EAST VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2024 (USD MILLION)
  • TABLE 262. MIDDLE EAST VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2025-2032 (USD MILLION)
  • TABLE 263. MIDDLE EAST VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2024 (USD MILLION)
  • TABLE 264. MIDDLE EAST VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2025-2032 (USD MILLION)
  • TABLE 265. MIDDLE EAST VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 266. MIDDLE EAST VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 267. MIDDLE EAST VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2024 (USD MILLION)
  • TABLE 268. MIDDLE EAST VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2025-2032 (USD MILLION)
  • TABLE 269. MIDDLE EAST VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2024 (USD MILLION)
  • TABLE 270. MIDDLE EAST VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2025-2032 (USD MILLION)
  • TABLE 271. MIDDLE EAST VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2024 (USD MILLION)
  • TABLE 272. MIDDLE EAST VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2025-2032 (USD MILLION)
  • TABLE 273. MIDDLE EAST VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 274. MIDDLE EAST VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 275. MIDDLE EAST VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 276. MIDDLE EAST VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 277. AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 278. AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 279. AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 280. AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 281. AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2024 (USD MILLION)
  • TABLE 282. AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2025-2032 (USD MILLION)
  • TABLE 283. AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2024 (USD MILLION)
  • TABLE 284. AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2025-2032 (USD MILLION)
  • TABLE 285. AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 286. AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 287. AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2024 (USD MILLION)
  • TABLE 288. AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2025-2032 (USD MILLION)
  • TABLE 289. AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2024 (USD MILLION)
  • TABLE 290. AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2025-2032 (USD MILLION)
  • TABLE 291. AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2024 (USD MILLION)
  • TABLE 292. AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2025-2032 (USD MILLION)
  • TABLE 293. AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 294. AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 295. AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 296. AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 297. ASIA-PACIFIC VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 298. ASIA-PACIFIC VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 299. ASIA-PACIFIC VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 300. ASIA-PACIFIC VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 301. ASIA-PACIFIC VASCULAR CLOSURE DEVICE MARK